Omapatrilat vasopeptidase inhibitor

BMS-186716 - BMS 186716 - Vanlev - omapatrilat

Heart failure

All type of patients:  2 trials  - OVERTURE - IMPRESS

omapatrilat vs enalapril

No demonstrated result
omapatrilat vs lisinopril

No demonstrated result

suggested Death from any cause or hospitalization for heart failure by 48% (not demonstrated)




- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons